PubMed=12780797; DOI=10.1046/j.1365-2141.2003.04359.x
Zhang Y., Nagata H., Ikeuchi T., Mukai H., Oyoshi M.K., Demachi A., Morio T., Wakiguchi H., Kimura N., Shimizu N., Yamamoto K.
Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Br. J. Haematol. 121:805-814(2003)

PubMed=22102884; DOI=10.1371/journal.pone.0027271; PMCID=PMC3213120
Ramakrishnan R., Donahue H., Garcia D., Tan J., Shimizu N., Rice A.P., Ling P.D.
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
PLoS ONE 6:e27271.1-e27271.12(2011)

PubMed=36094314; DOI=10.1128/JVI.00739-22; PMCID=PMC9517713
Ding W.-Y., Wang C., Narita Y., Wang H.-B., Leong M.M.L., Huang A., Liao Y.-F., Liu X.-F., Okuno Y., Kimura H., Gewurz B.E., Teng M.-X., Jin S.-L., Sato Y., Zhao B.
The Epstein-Barr virus enhancer interaction landscapes in virus-associated cancer cell lines.
J. Virol. 96:e00739.22.1-e00739.22.11(2022)